Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
MrWhy.com » Videos » Pharmacogenomic Testing and Breast Cancer: The Example of Cyp2D6 and Tamoxifen
Pharmacogenomic Testing and Breast Cancer: The Example of Cyp2D6 and Tamoxifen
Pharmacogenomic Testing and Breast Cancer: The Example of Cyp2D6 and Tamoxifen
Report
Pharmacogenomic Testing and Breast Cancer: The Example of Cyp2D6 and Tamoxifen
Genomic heterogeneity is emerging as an important factor in determining tamoxifen benefit in breast cancer. Dr. Hannah Linden, Associate Professor of Medicine at the University of Washington, and a breast cancer oncologist at the SCCA and HMC will review recent laboratory and clinical trial evidence regarding tamoxifen metabolism and the impact of CYP2D6 pharacogenomic profiling. From the Series:Laboratory Medicine Grand Rounds
Channel: ResearchChannel
Category: Health & Fitness
Video Length: 0
Date Found: February 12, 2009
Date Produced: November 14, 2007
View Count: 14
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.